Private Equity Other Private Equity/Strategic Investments
Serum Institute buys 20% stake in US-based needle-free injection system co. IntegriMedical
Source IntegriMedical (opens in a new tab)Economic Times (opens in a new tab)
Pune-based Serum Institute of India (SII) has acquired a 20% stake in US-headquartered IntegriMedical .Bainbridge, Indiana-headquartered IntegriMedical has developed a patented needle-free injection system (N-FIS) that utilises high-velocity jet streams using mechanical power for administering biologics and drugs. N-FIS is set to be made available in the Indian market.